UK study will reimburse egg donors for costs of in vitro fertilisation

doi:10.1136/bmj.39339.361181.DB

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ news articles:

From

The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
Countdown to London 2012: BMJ Group's Olympics portal highlights latest Olympics and sports medicine-themed research, comment and learning
Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
Our online table of contents is updated at least twice each day. Read all articles published in the last 7 days.
OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Susan Mayor

London

Women will be reimbursed about half the cost of their in vitro fertilisation in return for donating “surplus” eggs for stem cell research, in the first study funded by the UK Medical Research Council (MRC) that will pay participants.

The MRC announced last week that it is funding a research proposal from the North East England Stem Cell Institute (NESCI), based in Newcastle, to find ways of improving the efficiency of therapeutic cloning. This technique is designed to create stem cells specific to a patient that might eventually be used to treat conditions in which new cells could be therapeutic—such as diabetes, heart disease, and Parkinson's disease.

Out of the funding of £470 000 (€680 000; $950 000) for the research, the MRC will provide £150 000 to reimburse part of the cost of treatment for women …